Neuroscience
From The New York Times:
Biotech Tries to Shrug Off Setbacks
By JAMES FLANIGAN
Published: September 17, 2009
"While some investors are pulling back, life sciences companies continue to innovate, and hope the capital to expand will come."
Read the piece
- Rough Times For Uk Neuroscience
From The Guardian: Cuts disastrous for brain science research, academics warn At least 30 neuroscience units to go under cuts proposed by Biotechnology and Biological Sciences Research Council Ian Sample guardian.co.uk Thursday 10 February 2011 21.14...
- Patient Advocacy
...
- Business World: "the Brain Industry"
From The Seattle Times:Biotech Watch: Biotech companies scramble to develop brain-related products By Steve Johnson Knight Ridder Newspapers The Seattle Times Monday, July 25, 2005 SAN JOSE, Calif. — The prospect of a billion people nearing the age...
- Legal World: Amgen, Gdnf Clinical Trial, And Parkinson Disease
From The New York Times, concerning glial cell line-derived neurotrophic factor (GDNF):Judge Rejects Patients' Suit to Get Test Drug By ANDREW POLLACK The New York Times Published: June 8, 2005 A federal judge has denied a request by two people...
- Tysabri (natalizumab): Another Case Of Pml
A third case of progressive multifocal leukoencephalopathy (PML), as reported via The New York Times website: M.S. Drug Tied to a Death Published: March 31, 2005 By Bloomberg News Biogen Idec and the Elan Corporation said that a third patient had developed...
Neuroscience
Business World: Biotechnology & Venture Capital
From The New York Times:
Biotech Tries to Shrug Off Setbacks
By JAMES FLANIGAN
Published: September 17, 2009
"While some investors are pulling back, life sciences companies continue to innovate, and hope the capital to expand will come."
Read the piece
- Rough Times For Uk Neuroscience
From The Guardian: Cuts disastrous for brain science research, academics warn At least 30 neuroscience units to go under cuts proposed by Biotechnology and Biological Sciences Research Council Ian Sample guardian.co.uk Thursday 10 February 2011 21.14...
- Patient Advocacy
...
- Business World: "the Brain Industry"
From The Seattle Times:Biotech Watch: Biotech companies scramble to develop brain-related products By Steve Johnson Knight Ridder Newspapers The Seattle Times Monday, July 25, 2005 SAN JOSE, Calif. — The prospect of a billion people nearing the age...
- Legal World: Amgen, Gdnf Clinical Trial, And Parkinson Disease
From The New York Times, concerning glial cell line-derived neurotrophic factor (GDNF):Judge Rejects Patients' Suit to Get Test Drug By ANDREW POLLACK The New York Times Published: June 8, 2005 A federal judge has denied a request by two people...
- Tysabri (natalizumab): Another Case Of Pml
A third case of progressive multifocal leukoencephalopathy (PML), as reported via The New York Times website: M.S. Drug Tied to a Death Published: March 31, 2005 By Bloomberg News Biogen Idec and the Elan Corporation said that a third patient had developed...